Clinical Trial Update: Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update comparing rhTPO plus cyclosporine versus cyclosporine alone in transfusion-dependent aplastic anemia (TD-NSAA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Transfusion-dependent Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia, Transfusion-dependent Anemia | Phase 4 | Status: NOT_YET_RECRUITING